share_log
Reuters ·  Apr 30 08:09
Nautilus Biotechnology Inc: Cash, Cash Equivalents, and Investments Were $247.7 Mln as of March 31, 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment